Evidence map›Paper›PMID 16449191›Full record

ArticleThe Journal of cell biology2006

AP-2alpha: a regulator of EGF receptor signaling and proliferation in skin epidermis.

Xuan Wang, Diana Bolotin, David H Chu, Lisa Polak, Trevor Williams, Elaine Fuchs

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of cell biology, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 53 papers.

0numbers the graph read from it
0cells of the map it votes in
53citing papers in PubMed
2.8field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

53 citing papers in PubMed, 88 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Xuan WangThe Howard Hughes Medical Institute, Rockefeller University, New York, NY 10021, USA.
Diana Bolotin
David H Chu
Lisa Polak
Trevor Williams
Elaine Fuchs
Rockefeller University · USHoward Hughes Medical Institute · USUniversity of Colorado Health · US

Funding

MEDICAL SCIENTIST TRAININGT32GM007281 · NIGMS · UNIVERSITY OF CHICAGO · PI CLARK, MARCUS RAMSAY · 1985 to 2022
$32.1M
VITAMIN A AND KERATINIZATION IN HUMAN EPITHELIAL CELLSR01AR031737 · NIAMS · UNIVERSITY OF CHICAGO · PI ELAINE FUCHS · 1986 to 2026
$16.6M
THE ROLE OF AP-2 IN CRANIOFACIAL DEVELOPMENTR01DE012728 · NIDCR · YALE UNIVERSITY · PI WILLIAMS, TREVOR J · 1998 to 2013
$5.5M
RESEARCH TRAINING PROGRAM IN DERMATOLOGYT32AR007190 · NIAMS · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI FREEDBERG, IRWIN M · 1986 to 2005
$1.1M
TRANSCRIPTION FACTOR AP-2 IN MAMMARY GLAND DEVELOPMENTR01CA077833 · NCI · YALE UNIVERSITY · PI WILLIAMS, TREVOR J · 1998 to 2001
$579k
NCI NIH HHS R01-CA77833NIAMS NIH HHS 5-T3-AR07190NIAMS NIH HHS R01 AR031737NIAMS NIH HHS R01-AR31737NIAMS NIH HHS T32 AR007190NIDCR NIH HHS R01 DE012728NIDCR NIH HHS R01-DE12728NIGMS NIH HHS 5-T32-GM07281NIGMS NIH HHS T32 GM007281
6 · The paper itself

Abstract

AP-2 transcription factors have been implicated in epidermal biology, but their functional significance has remained elusive. Using conditional knockout technology, we show that AP-2alpha is essential for governing the balance between growth and differentiation in epidermis. In vivo, epidermis lacking AP-2alpha exhibits elevated expression of the epidermal growth factor receptor (EGFR) in the differentiating layers, resulting in hyperproliferation when the receptors are activated. Chromatin immunoprecipitation and promoter activity assays identify EGFR as a direct target gene for AP-2alpha repression, and, in the absence of AP-2alpha, this is manifested primarily in excessive EGF-dependent phosphoinositol-3 kinase/Akt activity. Together, our findings unveil a hitherto unrecognized repressive role for AP-2alpha in governing EGFR gene transcription as cells exit the basal layer and withdraw from the cell cycle. These results provide insights into why elevated AP-2alpha levels are often associated with terminal differentiation and why tumor cells often display reduced AP-2alpha and elevated EGFR proteins.

Indexed as

AnimalsAnimals, NewbornCalciumCaspase 3CaspasesCell ProliferationChromatin ImmunoprecipitationChromonesDermisDNAEmbryo, MammalianEnzyme InhibitorsEpidermal CellsEpidermal Growth FactorEpidermisErbB Receptors2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-oneCalciumCasp3 protein, mouseCaspase 3CaspasesChromonesCre recombinaseDNAEnzyme InhibitorsEpidermal Growth FactorErbB ReceptorsIntegrasesKeratinsKi-67 AntigenMorpholinesProto-Oncogene Proteins c-aktQuinazolinesRTKI cpdTetradecanoylphorbol AcetateTranscription Factor AP-2Transforming Growth Factor alphaTyrphostins

Identifiers

PMID16449191
PMCPMC2063650
OpenAlexW1965235767

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.